Stimulus bill packs a windfall for FDA and Covid-19 drug, vaccine developers

Biopharma companies and the FDA will be mostly pleased with the latest congressional Covid-19 relief package, which offers billions in new funds to fight the pandemic. The Senate signed off on the $1.9 trillion bill on Saturday afternoon and the House is expected to give its OK tomorrow.